Close Menu

NEW YORK (GenomeWeb) – Personalis today filed an amended prospectus with the US Securities and Exchange Commission to price an initial public offering of 6.7 million shares of common stock at $14 to $16 per share.

The company has also granted the underwriters the right to purchase an additional 1 million shares of stock to cover any over-allotments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.